These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12838956)

  • 1. Are health technology assessments a reliable tool in th analysis of the clinical value of PET in oncology? Who audits the auditors?
    Højgaard L
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):637-41. PubMed ID: 12838956
    [No Abstract]   [Full Text] [Related]  

  • 2. The need for Health Technology Assessments of PET.
    Van Tinteren H; Hoekstra OS; Boers M
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1438-9; author reply 1439. PubMed ID: 12898206
    [No Abstract]   [Full Text] [Related]  

  • 3. Health technology assessment of PET in oncology: re Eur J Nucl Med Mol Imaging 2003; 30:637-641.
    Kristensen FB; Adams E; Briones E; Coburn D; Facey K; Hansen NW; Hoeksema J; Mørland B
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):295-7; author reply 297-8; discussion 298. PubMed ID: 15129712
    [No Abstract]   [Full Text] [Related]  

  • 4. The need for independent physics advice.
    Bergmann H
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):491-3. PubMed ID: 12785357
    [No Abstract]   [Full Text] [Related]  

  • 5. Perspectives on "early dialogue" between a manufacturer and health technology assessment agencies.
    Geisler BP
    Value Health; 2011 Jun; 14(4):607. PubMed ID: 21669386
    [No Abstract]   [Full Text] [Related]  

  • 6. Health technology assessment (HTA) increasingly important in spine research.
    van Tulder M
    Eur Spine J; 2011 Jul; 20(7):999-1000. PubMed ID: 21720729
    [No Abstract]   [Full Text] [Related]  

  • 7. Is PET the future of nuclear medicine?
    Maisey M
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1045-6. PubMed ID: 12827314
    [No Abstract]   [Full Text] [Related]  

  • 8. Is PET the future of nuclear medicine?
    Bailey DL
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1047-9. PubMed ID: 12811533
    [No Abstract]   [Full Text] [Related]  

  • 9. Biosimilars: evidential standards for health technology assessment.
    Hughes DA
    Clin Pharmacol Ther; 2010 Mar; 87(3):257-61. PubMed ID: 20160743
    [No Abstract]   [Full Text] [Related]  

  • 10. [Netherlands' experience in positron emission tomography in thoracic oncology].
    Hoekstra O
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S25-7. PubMed ID: 12538930
    [No Abstract]   [Full Text] [Related]  

  • 11. HTBS advises new PET facility in Scotland.
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):488. PubMed ID: 12723556
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology].
    Granov AM; Tiushin LA; Tlostanova MS; Kostenikov NA; Ryzhkova DV; Savello VE; Stanzhevskiĭ AA
    Vopr Onkol; 2003; 49(5):563-73. PubMed ID: 14682126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why rankings of biomedical image analysis competitions should be interpreted with care.
    Maier-Hein L; Eisenmann M; Reinke A; Onogur S; Stankovic M; Scholz P; Arbel T; Bogunovic H; Bradley AP; Carass A; Feldmann C; Frangi AF; Full PM; van Ginneken B; Hanbury A; Honauer K; Kozubek M; Landman BA; März K; Maier O; Maier-Hein K; Menze BH; Müller H; Neher PF; Niessen W; Rajpoot N; Sharp GC; Sirinukunwattana K; Speidel S; Stock C; Stoyanov D; Taha AA; van der Sommen F; Wang CW; Weber MA; Zheng G; Jannin P; Kopp-Schneider A
    Nat Commun; 2018 Dec; 9(1):5217. PubMed ID: 30523263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using health technology assessment to identify gaps in evidence and inform study design for comparative effectiveness research.
    Tunis SR; Turkelson C
    J Clin Oncol; 2012 Dec; 30(34):4256-61. PubMed ID: 23071248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical PET in oncology.
    Biersack HJ; Bender H; Ruhlmann J; Oehr P; Guhlke S; Grünwald F
    Rev Esp Med Nucl; 2000 Jun; 19(3):219-24. PubMed ID: 11062087
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid response in health technology assessment: a Delphi study for a Brazilian guideline.
    Silva MT; Silva END; Barreto JOM
    BMC Med Res Methodol; 2018 Jun; 18(1):51. PubMed ID: 29884121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission and computed X-ray tomography: a coming together.
    Costa DC; Visvikis D; Crosdale I; Pigden I; Townsend C; Bomanji J; Prvulovich E; Lonn A; Ell PJ
    Nucl Med Commun; 2003 Apr; 24(4):351-8. PubMed ID: 12673162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health technology assessment in Europe.
    Kristensen FB
    Scand J Public Health; 2009 Jun; 37(4):335-9. PubMed ID: 19493989
    [No Abstract]   [Full Text] [Related]  

  • 19. Audit of nuclear medicine scientific and technical standards.
    Jarritt PH; Perkins AC; Woods SD;
    Nucl Med Commun; 2004 Aug; 25(8):771-5. PubMed ID: 15266170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health technology assessment.
    Hailey D
    Singapore Med J; 2006 Mar; 47(3):187-92; quiz 193. PubMed ID: 16518551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.